Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Intellia Therapeutics Inc (NASDAQ: NTLA) closed at $9.54 down -7.56% from its previous closing price of $10.32. In other words, the price has decreased by -$7.56 from its previous closing price. On the day, 3.07 million shares were traded. NTLA stock price reached its highest trading level at $9.9 during the session, while it also had its lowest trading level at $9.32.
Ratios:
For a deeper understanding of Intellia Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.73 and its Current Ratio is at 6.73. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on January 27, 2025, Downgraded its rating to Equal-Weight and sets its target price to $11 from $56 previously.
On February 23, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $136 to $32.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 29 ’25 when Bhanji Muna sold 265 shares for $9.97 per share. The transaction valued at 2,642 led to the insider holds 19,468 shares of the business.
Dube Michael P sold 1,372 shares of NTLA for $16,711 on Jan 03 ’25. The VP, Chief Accounting Officer now owns 45,640 shares after completing the transaction at $12.18 per share. On Jan 03 ’25, another insider, BASTA JAMES, who serves as the EVP, General Counsel of the company, sold 7,074 shares for $12.18 each. As a result, the insider received 86,161 and left with 74,497 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTLA now has a Market Capitalization of 971639488 and an Enterprise Value of 415144384. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.55 while its Price-to-Book (P/B) ratio in mrq is 1.01. Its current Enterprise Value per Revenue stands at 9.635 whereas that against EBITDA is -0.787.
Stock Price History:
The Beta on a monthly basis for NTLA is 1.80, which has changed by -0.61159205 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, NTLA has reached a high of $34.87, while it has fallen to a 52-week low of $9.25. The 50-Day Moving Average of the stock is -22.75%, while the 200-Day Moving Average is calculated to be -51.10%.
Shares Statistics:
For the past three months, NTLA has traded an average of 2.77M shares per day and 2921170 over the past ten days. A total of 101.80M shares are outstanding, with a floating share count of 99.72M. Insiders hold about 2.09% of the company’s shares, while institutions hold 91.52% stake in the company. Shares short for NTLA as of 1736899200 were 24060839 with a Short Ratio of 8.67, compared to 1734048000 on 19807004. Therefore, it implies a Short% of Shares Outstanding of 24060839 and a Short% of Float of 26.91.
